The alarming rise and spread of antimicrobial resistance is an increasing global challenge and there is considerable interest and an acknowledged benefit in the [...]
About Matt PeakeThis author has not yet filled in any details.
So far Matt Peake has created 33 blog entries.
Proceeds will be used to establish clinical proof of concept for three novel haematological cancer programs UCL Business spinout company, Autolus Limited, a cli [...]
• The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development • Speaking from the W [...]
Autolus announces initiation of the AMELIA and ALEXANDER studies for AUTO3: phase I/II studies in paediatric ALL and DLBCLMatt Peake 2017-10-03T09:26:01+00:00
AUTO3 is the first dual targeting CAR-T cell therapy to enter clinical studies targeting CD19 and CD22 with independently-acting CARs. UCL Business spinout comp [...]
Autolus announces first-dose cohort completed in APRIL study of AUTO2: a phase I/II study in patients with multiple myelomaMatt Peake 2017-10-03T09:26:38+00:00
AUTO2 is the first dual targeting CAR-T Cell therapy in clinical development for the treatment of multiple myeloma UCL Business spinout company, Autolus Limited [...]
UCL academics will assist TCB with development of treatment for leukemia. Clinical programme will see first patients treated in 2018 Scottish immunotherapy comp [...]
Most cameras just record colour but now the 3D shapes of objects, captured through only a single lens, can be accurately estimated using new software developed [...]
The first patient in an international trial of a new liver dialysis system has been recruited at the Royal Free Hospital in London. The device, called DIALIVE, [...]
Chirp, a UCLB spinout company, has partnered with Chicago-based toy company Hijinx to create toys based on Netflix original series Beat Bugs. The worldwide excl [...]
UCLB hosted its annual summer reception where guests enjoyed refreshing drinks and delicious canapés under UCL’s prestigious portico. UCLB’s Managing Director, [...]